Literature DB >> 3979018

Staphylococcus epidermidis arthritis following catheter-induced bacteremia in a neutropenic patient.

J P Hutton, B H Hamory, J T Parisi, L J Strausbaugh.   

Abstract

Sepsis due to methicillin-resistant Staphylococcus epidermidis occurred in a neutropenic man during management with a Hickman-Broviac catheter. Despite catheter removal and 10 days of i.v. cefazolin therapy, he developed septic arthritis 6 weeks later in a nonprosthetic hip joint. S. epidermidis was isolated from the joint and found to have plasmid and phage susceptibility patterns identical to the previous blood isolate. This case is the first to document a metastatic infection from catheter-associated S. epidermidis bacteremia. It suggests that cephalosporins may not be optimal in such infections despite in vitro sensitivity. Vancomycin appears to be the drug of choice for S. epidermidis bacteremia in the neutropenic population.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3979018     DOI: 10.1016/0732-8893(85)90020-3

Source DB:  PubMed          Journal:  Diagn Microbiol Infect Dis        ISSN: 0732-8893            Impact factor:   2.803


  9 in total

1.  Nucleotide sequence of the constitutive macrolide-lincosamide-streptogramin B resistance plasmid pNE131 from Staphylococcus epidermidis and homologies with Staphylococcus aureus plasmids pE194 and pSN2.

Authors:  B C Lampson; J T Parisi
Journal:  J Bacteriol       Date:  1986-09       Impact factor: 3.490

2.  Naturally occurring Staphylococcus epidermidis plasmid expressing constitutive macrolide-lincosamide-streptogramin B resistance contains a deleted attenuator.

Authors:  B C Lampson; J T Parisi
Journal:  J Bacteriol       Date:  1986-05       Impact factor: 3.490

Review 3.  Coagulase-negative staphylococci and the epidemiological typing of Staphylococcus epidermidis.

Authors:  J T Parisi
Journal:  Microbiol Rev       Date:  1985-06

4.  Phenotypic variation of Staphylococcus epidermidis slime production in vitro and in vivo.

Authors:  G D Christensen; L M Baddour; W A Simpson
Journal:  Infect Immun       Date:  1987-12       Impact factor: 3.441

5.  Comparison of epidemiologic markers for Staphylococcus epidermidis.

Authors:  J T Parisi; B C Lampson; D L Hoover; J A Khan
Journal:  J Clin Microbiol       Date:  1986-07       Impact factor: 5.948

Review 6.  Laboratory, clinical, and epidemiological aspects of coagulase-negative staphylococci.

Authors:  M A Pfaller; L A Herwaldt
Journal:  Clin Microbiol Rev       Date:  1988-07       Impact factor: 26.132

7.  Septicemia due to coagulase-negative Staphylococcus in a community hospital.

Authors:  J Righter
Journal:  CMAJ       Date:  1987-07-15       Impact factor: 8.262

8.  Phenotypic variation of Staphylococcus epidermidis in infection of transvenous endocardial pacemaker electrodes.

Authors:  L M Baddour; L P Barker; G D Christensen; J T Parisi; W A Simpson
Journal:  J Clin Microbiol       Date:  1990-04       Impact factor: 5.948

9.  Invasive infections with a coagulase-negative staphylococcus in an immunocompromised patient: case report and review of the literature.

Authors:  Goda Choi; Maaike P J van den Borne; Caroline E Visser; Marie José Kersten; Arnon P Kater
Journal:  Ann Hematol       Date:  2008-04-03       Impact factor: 3.673

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.